BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Genentech

Genentech logo

Founded
1976
Patents
129
Clinical Trials
460
Publications
102

Provider of a drug development platform intended to improve drug delivery and develop novel and niche generic medical products. The company's drug development platform is poorly water soluble, features controlled release and specializes in central nervous system and oncology compound, enabling pharmaceuticals companies to develop drugs and drug-based products based on patient compliance.

Get access to BPT Crunch to view additional information about this company